Jasmine Seror
CIK: 0002120241
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CollPlant Biotechnologies Ltd
Discretionary Trading P&L
Holdings
Transaction History (0 total)
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
Jasmine Seror files insider reports with the SEC as VP Product Development of CollPlant Biotechnologies Ltd (CLGN).
About Seror Jasmine
Seror Jasmine (SEC CIK 0002120241) files insider reports with the SEC as VP Product Development of CollPlant Biotechnologies Ltd (CLGN).
Signal8 holds 1 ownership filing by Seror Jasmine, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Seror Jasmine's filings is in REHOVOT.
Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)
- Shlomi Ruty Ben, Director
- Rotem Eran, Deputy CEO and CFO
- Abelis Bar Berta, VP Legal
- Evans Hugh M, Director
- Tal Yehiel, Chief Executive Officer
- Lask Alisa, Director